CERVIDIL Drug Patent Profile
✉ Email this page to a colleague
When do Cervidil patents expire, and when can generic versions of Cervidil launch?
Cervidil is a drug marketed by Ferring Pharms Inc and is included in one NDA.
The generic ingredient in CERVIDIL is dinoprostone. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dinoprostone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CERVIDIL?
- What are the global sales for CERVIDIL?
- What is Average Wholesale Price for CERVIDIL?
Summary for CERVIDIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,901 |
| Drug Prices: | Drug price information for CERVIDIL |
| What excipients (inactive ingredients) are in CERVIDIL? | CERVIDIL excipients list |
| DailyMed Link: | CERVIDIL at DailyMed |
Recent Clinical Trials for CERVIDIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Intermountain Health Care, Inc. | Phase 3 |
| Regina Qu'Appelle Health Region | N/A |
| Saskatchewan Health Authority - Regina Area | N/A |
Pharmacology for CERVIDIL
| Drug Class | Prostaglandin Analog |
US Patents and Regulatory Information for CERVIDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | CERVIDIL | dinoprostone | INSERT, EXTENDED RELEASE;VAGINAL | 020411-001 | Mar 30, 1995 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CERVIDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | CERVIDIL | dinoprostone | INSERT, EXTENDED RELEASE;VAGINAL | 020411-001 | Mar 30, 1995 | ⤷ Sign Up | ⤷ Sign Up |
| Ferring Pharms Inc | CERVIDIL | dinoprostone | INSERT, EXTENDED RELEASE;VAGINAL | 020411-001 | Mar 30, 1995 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CERVIDIL
See the table below for patents covering CERVIDIL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| European Patent Office | 0016654 | COMPOSITION FOR THE CONTROLLED RELEASE OF A PROSTAGLANDINE AND PROCESS FOR ITS PREPARATION | ⤷ Sign Up |
| United Kingdom | 9100928 | ⤷ Sign Up | |
| Austria | 166565 | ⤷ Sign Up | |
| South Africa | 8001659 | ⤷ Sign Up | |
| South Africa | 8001654 | ⤷ Sign Up | |
| Hong Kong | 79785 | CONTROLLED RELEASE COMPOSITIONS (I) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
